Search by Drug Name or NDC

    NDC 69315-0161-10 DOXEPIN HYDROCHLORIDE 75 mg/1 Details

    DOXEPIN HYDROCHLORIDE 75 mg/1

    DOXEPIN HYDROCHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharma, LLC. The primary component is DOXEPIN HYDROCHLORIDE.

    Product Information

    NDC 69315-0161
    Product ID 69315-161_472664f9-ac9d-408e-9077-a711815717a0
    Associated GPIs 58200040100120
    GCN Sequence Number 046091
    GCN Sequence Number Description doxepin HCl CAPSULE 75 MG ORAL
    HIC3 H2U
    HIC3 Description TRICYCLIC ANTIDEPRESSANTS,REL.NON-SEL.REUPT-INHIB
    GCN 16568
    HICL Sequence Number 001650
    HICL Sequence Number Description DOXEPIN HCL
    Brand/Generic Generic
    Proprietary Name DOXEPIN HYDROCHLORIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name DOXEPIN HYDROCHLORIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name DOXEPIN HYDROCHLORIDE
    Labeler Name Leading Pharma, LLC
    Pharmaceutical Class Tricyclic Antidepressant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211619
    Listing Certified Through 2024-12-31

    Package

    NDC 69315-0161-10 (69315016110)

    NDC Package Code 69315-161-10
    Billing NDC 69315016110
    Package 1000 CAPSULE in 1 PACKAGE (69315-161-10)
    Marketing Start Date 2021-04-15
    NDC Exclude Flag N
    Pricing Information N/A